Collecting duct carcinoma with acquired cystic disease of the kidney in a long‐term hemodialysis patient

Sakura, Mizuaki; Masuda, Hitoshi; Saito, Kazutaka; Koga, Fumitaka; Kawakami, Satoru; Kihara, Kazunori

doi:10.1111/j.1442-2042.2007.01924.x

Cited by 3 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…86 The spectrum of renal tumors associated with end-stage renal disease is quite varied and in single cases and small series clear cell renal cell carcinomas, papillary renal cell carcinomas, chromophobe renal carcinoma, collecting-duct carcinoma, tubulocystic carcinoma, angiomyolipoma, oncocytoma and mixed epithelial and stromal tumor have been reported. [87][88][89][90][91][92][93][94] In up to 70% of cases more than one tumor was present in a single kidney. 95 In a detailed study of 66 tumor-bearing kidneys from patients with end-stage renal disease, a wide spectrum of renal neoplasia was noted.…”

Section: Carcinoma Associated With End-stage Renal Diseasementioning

confidence: 99%

Uncommon and recently described renal carcinomas

2009

View full text Add to dashboard Cite

Major consensus conferences held over a decade ago laid the foundations for the current (2004) WHO classification of renal carcinoma. Clear cell, papillary and chromophobe carcinomas account for 85-90% carcinomas seen in routine practice. The remaining 10-15% of carcinomas consist of rare sporadic and hereditary tumors, some of which had been long recognized, but many of which only emerged as distinct entities in the decade leading up to the WHO publication. Collecting-duct carcinoma is a rare, often lethal form of carcinoma. Medullary carcinoma associated with sickle cell trait, has emerged as a distinctive tumor showing some overlapping features with upper tract urothelial carcinoma. Mucinous tubular and spindle-cell carcinoma and tubulocystic carcinoma were earlier considered as patterns of low-grade collecting-duct carcinoma, but are now recognized as separate tumor entities. Carcinomas associated with somatic translocations of TFE3 and TFEB comprise a significant proportion of pediatric renal carcinomas. Oncocytoid renal carcinomas in neuroblastoma survivors was recognized as a unique tumor category in the WHO classification. Renal carcinoma associated with end-stage renal disease is now recognized as having distinct morphological patterns and behavior. In addition there is a group of rare recently described carcinomas, including clear cell papillary carcinoma, oncocytic papillary renal cell carcinoma, follicular renal carcinoma and leiomyomatous renal cell carcinoma. It behooves the surgical pathologist to not only be capable of diagnosing the common forms of renal cancer, but also to be aware of the rare types of renal carcinoma, many of which have emerged in recent years.

show abstract

Section: Carcinoma Associated With End-stage Renal Diseasementioning

confidence: 99%

Uncommon and recently described renal carcinomas

2009

View full text Add to dashboard Cite

show abstract

“…1,3,[17][18][19][20][21][22][23][24][25] From these publications it was suggested that clear cell carcinoma, papillary carcinoma and chromophobe carcinoma were the tumour types found, with papillary renal carcinoma over-represented in this group of patients in comparison with the general population. Oncoytoma, 20,[26][27][28][29][30] collecting duct carcinoma 31 and sarcomatoid renal carcinoma 14,32,33 have all been described mostly as isolated cases. Recent data have challenged this view and supported the existence of two tumour types specific to end-stage renal failure (ESRF) and ACKD patients.…”

Section: Pathology Of Renal Carcinoma Associated With Ackdmentioning

confidence: 99%

Renal cell carcinoma in acquired cystic kidney disease

Fleming¹

2010

Histopathology

View full text Add to dashboard Cite

There has recently been recognition of new forms of renal cell carcinoma arising in the kidneys of patients with acquired cystic kidney disease. These tumours are morphologically unique and appear to represent tumour induction in response to high levels of oxalate deposition in the kidneys. In this commentary I will review the most recent data including evidence published in Histopathology for a loop of Henle phenotype, which may be important in oxalate transport.

show abstract

“…Since December 2006 two of the seven patients have died of the disease. Case 2 was spindle cell carcinoma and case 3 was Bellini duct carcinoma with lymph node metastasis 10 . Since the prognosis of RCC in dialysis patients have been reported as being equivalent to that of sporadic RCC, 9 attending physicians should examine dialysis patients with suspicion of RCC bearing in mind that life‐threatening aggressive cancer can arise.…”

Section: Discussionmentioning

confidence: 99%

Sequential bilateral minimum incision endoscopic radical nephrectomy in dialysis patients with bilateral renal cell carcinomas

Sakura¹,

Kawakami²,

Masuda³

et al. 2007

Int J of Urology

Self Cite

View full text Add to dashboard Cite

Since 1998, we have performed minimum incision endoscopic surgery (MIES) for renal cell carcinoma (RCC). For seven dialysis patients with bilateral RCC, we have performed sequential bilateral MIES radical nephrectomy. It was carried out by retroperitoneal approach through a single minimum incision that narrowly permitted extraction of the specimen using endoscopy and direct stereovision, without trocar ports, without gas insufflation and without the insertion of the hands of operators into the operative field. Although six of the seven patients had multiple complications in addition to chronic renal failure (CRF), bilateral kidneys were successfully removed by sequential MIES radical nephrectomy without major operative complication. Postoperative recovery was prompt with all patients resuming oral feeding and walking by the second postoperative day. Sequential bilateral MIES radical nephrectomy, leaving the peritoneal cavity intact and without imposing circulatory stress caused by gas insufflation, is a feasible treatment for bilateral RCCs in dialysis patients.

show abstract

Collecting duct carcinoma with acquired cystic disease of the kidney in a long‐term hemodialysis patient

Cited by 3 publications

References 7 publications

Uncommon and recently described renal carcinomas

Uncommon and recently described renal carcinomas

Renal cell carcinoma in acquired cystic kidney disease

Sequential bilateral minimum incision endoscopic radical nephrectomy in dialysis patients with bilateral renal cell carcinomas

Contact Info

Product

Resources

About